Alector (ALEC) Cash from Operations Growth (5y) (2023 - 2026)
Alector (ALEC) Cash from Operations Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn |
| 10 | Alector | 167.54 Mn | -38.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12% |
| Dec 31, 2025 | 2.64% |
| Sep 30, 2025 | 4.45% |
| Jun 30, 2025 | -1.32% |
| Mar 31, 2025 | -13.47% |
| Dec 31, 2024 | -13.80% |
| Sep 30, 2024 | -11.94% |
| Jun 30, 2024 | -28.32% |
| Mar 31, 2024 | -21.09% |
| Dec 31, 2023 | -21.15% |
| Sep 30, 2023 | -15.79% |
| Jun 30, 2023 | -20.33% |
| Mar 31, 2023 | -17.74% |